1.2.40.0.34.10.170/static-2016-11-24T000000

Id	1.2.40.0.34.10.170	Gültigkeit	gültig ab 2016‑11‑24
Status	Definitiv	Versions-Label	4.0
Name	ELGA_Antibiotika	Anzeigename	ELGA_Antibiotika
Quell-Codesystem	2.16.840.1.113883.6.1
Level/ Typ Code Anzeigename Codesystem 0‑L 100-8 Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 101-6 Cefoperazone [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 103-2 Ceforanide [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 104-0 Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 105-7 Ceforanide [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 10653-4 Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 10654-2 Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 10697-1 Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 10698-9 Nystatin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 10720-1 Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 10721-9 Terbinafine [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 107-3 Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 108-1 Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 10868-8 Bacitracin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 109-9 Cefotaxime [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 121-4 Cefpodoxime [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 111-5 Cefotetan [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 112-3 Cefotetan [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 113-1 Cefotetan [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 115-6 Cefoxitin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 11575-8 Cefmetazole [Susceptibility] by Gradient strip 2.16.840.1.113883.6.1 0‑L 11576-6 Erythromycin+Sulfisoxazole [Susceptibility] by Gradient strip 2.16.840.1.113883.6.1 0‑L 11577-4 Sulfamethoxazole [Susceptibility] by Gradient strip 2.16.840.1.113883.6.1 0‑L 11578-2 Sulfisoxazole [Susceptibility] by Gradient strip 2.16.840.1.113883.6.1 0‑L 116-4 Cefoxitin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 11-7 Amikacin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 117-2 Cefoxitin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 129-7 Cefsulodin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 119-8 Cefpodoxime [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 120-6 Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 123-0 Cefprozil [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 124-8 Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 12-5 Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 125-5 Cefprozil [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 138-8 Ceftizoxime [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 127-1 Cefsulodin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 128-9 Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 132-1 Ceftazidime [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 13-3 Amikacin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 133-9 Ceftazidime [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 134-7 Ceftazidime [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 136-2 Ceftizoxime [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 137-0 Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 13968-3 Penicillin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 140-4 Ceftriaxone [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 141-2 Ceftriaxone [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 142-0 Ceftriaxone [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 14332-1 Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 144-6 Cefuroxime Parenteral [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 145-3 Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 152-9 Cephaloglycin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 146-1 Cefuroxime Parenteral [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 148-7 Cephalexin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 149-5 Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 150-3 Cephalexin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 153-7 Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 154-5 Cephaloglycin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 156-0 Cephaloridine [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 157-8 Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 15-8 Amoxicillin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 158-6 Cephaloridine [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 160-2 Cephalothin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 16099-4 Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 161-0 Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 16100-0 Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 162-8 Cephalothin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 16387-3 Rifabutin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 16421-0 Azithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 164-4 Cephapirin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 165-1 Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 16-6 Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 16620-7 Clarithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 16623-1 Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 166-9 Cephapirin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 16830-2 Erythromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 16841-9 Ethambutol+Rifampin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 168-5 Cephradine [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 173-5 Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 176-8 Chlortetracycline [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 169-3 Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 170-1 Cephradine [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 172-7 Chloramphenicol [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 17-4 Amoxicillin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 174-3 Chloramphenicol [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 177-6 Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 178-4 Chlortetracycline [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 182-6 Cinoxacin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 1-8 Acyclovir [Susceptibility] 2.16.840.1.113883.6.1 0‑L 180-0 Cinoxacin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 181-8 Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 18946-4 Metronidazole [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18947-2 Mezlocillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18948-0 Minocycline [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18949-8 Miocamycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18950-6 Moxalactam [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18951-4 Nafcillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18952-2 Nalidixate [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18953-0 Neomycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18954-8 Netilmicin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18955-5 Nitrofurantoin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18956-3 Norfloxacin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18957-1 Novobiocin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18958-9 Nystatin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 184-2 Ciprofloxacin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 198-2 Cloxacillin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 185-9 Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 186-7 Ciprofloxacin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 188-3 Clarithromycin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 18855-7 5-Fluorocytosine [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18857-3 Almecillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18859-9 Amdinocillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18860-7 Amikacin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18861-5 Amoxicillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18862-3 Amoxicillin+Clavulanate [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18863-1 Amphotericin B [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18864-9 Ampicillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18865-6 Ampicillin+Sulbactam [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18866-4 Azithromycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18867-2 Azlocillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18868-0 Aztreonam [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18869-8 Bacampicillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18870-6 Bacitracin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18871-4 Butirosin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18872-2 Capreomycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18873-0 Carbenicillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18874-8 Cefaclor [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18875-5 Cefadroxil [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18876-3 Cefamandole [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18877-1 Cefatrizine [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18878-9 Cefazolin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18879-7 Cefepime [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18880-5 Cefixime [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18881-3 Cefmetazole [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18882-1 Cefodizime [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18883-9 Cefonicid [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18884-7 Cefoperazone [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18885-4 Ceforanide [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18886-2 Cefotaxime [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18887-0 Cefotetan [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18888-8 Cefoxitin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18889-6 Cefpirome [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18890-4 Cefpodoxime [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18891-2 Cefprozil [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18892-0 Cefsulodin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18893-8 Ceftazidime [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18894-6 Ceftizoxime [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18895-3 Ceftriaxone [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18896-1 Cefuroxime Parenteral [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18897-9 Cephalexin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18898-7 Cephaloglycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18899-5 Cephaloridine [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18900-1 Cephalothin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18901-9 Cephapirin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18902-7 Cephradine [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18903-5 Chloramphenicol [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18904-3 Chlortetracycline [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18905-0 Cinoxacin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18906-8 Ciprofloxacin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18907-6 Clarithromycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18908-4 Clindamycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18909-2 Clotrimazole [Susceptibility] 2.16.840.1.113883.6.1 0‑L 189-1 Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 18910-0 Cloxacillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18911-8 Colistimethate 2.16.840.1.113883.6.1 0‑L 18912-6 Colistin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18913-4 Cyclacillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18914-2 Cycloserine [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18915-9 Demeclocycline [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18916-7 Dicloxacillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18917-5 Doxycycline [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18918-3 Enoxacin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18919-1 Erythromycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18920-9 Erythromycin+Sulfisoxazole [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18921-7 Ethambutol [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18922-5 Ethionamide [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18923-3 Floxacillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18924-1 Fluconazole [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18926-6 Framycetin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18927-4 Fusidate [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18928-2 Gentamicin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18929-0 Gentamicin.high potency [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18930-8 Gramicidin D [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18931-6 Hetacillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18932-4 Imipenem [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18934-0 Isoniazid [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18935-7 Kanamycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18936-5 Kanamycin.high potency [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18937-3 Ketoconazole [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18938-1 Lincomycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18939-9 Lomefloxacin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18940-7 Loracarbef [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18941-5 Lymecycline [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18942-3 Meclocycline [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18943-1 Meropenem [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18944-9 Methacycline [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18945-6 Methicillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18959-7 Ofloxacin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18960-5 Oleandomycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18961-3 Oxacillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18962-1 Oxytetracycline [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18963-9 Pefloxacin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18964-7 Penicillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18965-4 Penicillin G [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18966-2 Penicillin V [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18967-0 Phenethicillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18968-8 Pipemidate [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18969-6 Piperacillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18970-4 Piperacillin+Tazobactam [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18971-2 Pivampicillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18972-0 Polymyxin B [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18973-8 Pyrazinamide [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18974-6 Rifampin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18975-3 Ristocetin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18976-1 Rolitetracycline [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18977-9 Rosoxacin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18978-7 Roxithromycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18979-5 Sisomicin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18980-3 Spectinomycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18981-1 Spiramycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18982-9 Streptomycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18983-7 Streptomycin.high potency [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18984-5 Sulfadiazine [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18985-2 Sulfamethoxazole [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18986-0 Sulfisoxazole [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18987-8 Sulfonamide [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18988-6 Talampicillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18989-4 Teicoplanin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18990-2 Temafloxacin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18991-0 Temocillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18992-8 Terbinafine [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18993-6 Tetracycline [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18994-4 Ticarcillin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18995-1 Ticarcillin+Clavulanate [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18996-9 Tobramycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18997-7 Trimethoprim [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18998-5 Trimethoprim+Sulfamethoxazole [Susceptibility] 2.16.840.1.113883.6.1 0‑L 18999-3 Troleandomycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 19-0 Amoxicillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 19000-9 Vancomycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 19001-7 Viomycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 190-9 Clarithromycin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 19149-4 Rifabutin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 192-5 Clindamycin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 193-3 Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 194-1 Clindamycin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 20375-2 Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 20376-0 Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 20377-8 Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 20378-6 Ceftizoxime [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 20379-4 Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 196-6 Cloxacillin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 197-4 Cloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 200-6 Colistimethate by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 201-4 Colistimethate by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 202-2 Colistimethate by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 20373-7 Amikacin [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 20374-5 Ampicillin+Sulbactam [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 20380-2 Erythromycin [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 20381-0 Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 20382-8 Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 20383-6 Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 20384-4 Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 20385-1 Rifampin [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 20386-9 Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 20387-7 Trimethoprim+Sulfamethoxazole [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 20388-5 Nitrofurazone [Susceptibility] 2.16.840.1.113883.6.1 0‑L 20389-3 Mupirocin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 20390-1 Silver sulfadiazine [Susceptibility] 2.16.840.1.113883.6.1 0‑L 20391-9 Mafenide [Susceptibility] 2.16.840.1.113883.6.1 0‑L 20396-8 Levofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 20397-6 Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 20460-2 Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 20461-0 Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 20462-8 Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 204-8 Colistin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 205-5 Colistin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 20629-2 Levofloxacin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 206-3 Colistin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 209-7 Cyclacillin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 20-8 Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 208-9 Cyclacillin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 210-5 Cyclacillin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 21070-8 Other Antibiotic [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 212-1 Cycloserine [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 21316-5 Grepafloxacin [Susceptibility] by Gradient strip 2.16.840.1.113883.6.1 0‑L 21367-8 Levofloxacin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 213-9 Cycloserine [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 214-7 Cycloserine [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 21-6 Amoxicillin+Clavulanate [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 216-2 Demeclocycline [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 217-0 Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 23636-4 Cefdinir [Susceptibility] 2.16.840.1.113883.6.1 0‑L 23637-2 Cefdinir [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 23638-0 Grepafloxacin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 23639-8 Grepafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 23640-6 Quinupristin+Dalfopristin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 218-8 Demeclocycline [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 220-4 Dicloxacillin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 221-2 Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 222-0 Dicloxacillin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 225-3 Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 224-6 Doxycycline [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 226-1 Doxycycline [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 228-7 Enoxacin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 229-5 Enoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 230-3 Enoxacin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 23-2 Amphotericin B [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 232-9 Erythromycin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 233-7 Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 234-5 Erythromycin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 236-0 Erythromycin+Sulfisoxazole [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 23607-5 Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 23608-3 Cycloserine [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 23609-1 Kanamycin [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 23610-9 Sparfloxacin [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 23611-7 Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 23612-5 Azithromycin [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 23613-3 Imipenem [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 23614-1 Trimethoprim [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 23615-8 Vancomycin [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 23616-6 Viomycin [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 23627-3 Clofazimine [Susceptibility] 2.16.840.1.113883.6.1 0‑L 23628-1 Sparfloxacin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 23629-9 Para aminosalicylate [Susceptibility] 2.16.840.1.113883.6.1 0‑L 23641-4 Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 23642-2 Trovafloxacin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 23643-0 Trovafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 23658-8 Other Antibiotic [Susceptibility] 2.16.840.1.113883.6.1 0‑L 23659-6 Apramycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 23709-9 Ceftiofur [Susceptibility] 2.16.840.1.113883.6.1 0‑L 23712-3 Enrofloxacin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 23740-4 Florfenicol [Susceptibility] 2.16.840.1.113883.6.1 0‑L 24-0 Amphotericin B [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 237-8 Erythromycin+Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 238-6 Erythromycin+Sulfisoxazole [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 23925-1 Penicillin [Susceptibility] by Gradient strip 2.16.840.1.113883.6.1 0‑L 244-4 Floxacillin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 240-2 Ethambutol [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 241-0 Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 242-8 Ethambutol [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 245-1 Floxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 246-9 Floxacillin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 249-3 Fluconazole [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 252-7 5-Fluorocytosine [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 248-5 Fluconazole [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 25452-4 Itraconazole [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 25-7 Amphotericin B [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 257-6 Framycetin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 250-1 Fluconazole [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 25174-4 Amikacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25175-1 Amikacin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25176-9 Amikacin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25177-7 Amikacin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25178-5 Amikacin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25179-3 Amikacin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25180-1 Ciprofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25181-9 Ciprofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25182-7 Kanamycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25183-5 Ethionamide 11 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25184-3 Rifampin 14 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25185-0 Streptomycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25186-8 Pyrazinamide 25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25187-6 Ethambutol 7.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25188-4 Ciprofloxacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25189-2 Ciprofloxacin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25190-0 Clarithromycin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25191-8 Clarithromycin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25192-6 Clarithromycin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25194-2 Ethambutol 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25195-9 Ethambutol 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25196-7 Ethionamide 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25198-3 Ethionamide 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25199-1 Rifabutin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25200-7 Rifabutin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25201-5 Rifabutin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25202-3 Rifampin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25203-1 Rifampin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25204-9 Rifampin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25205-6 Streptomycin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25206-4 Streptomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25207-2 Cycloserine 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25208-0 Cycloserine 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25209-8 Cycloserine 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25210-6 Capreomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25211-4 Capreomycin 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25212-2 Capreomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25213-0 Kanamycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25214-8 Kanamycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25215-5 Para aminosalicylate 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25216-3 Para aminosalicylate 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25217-1 Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25218-9 Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25219-7 Isoniazid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25220-5 Cefoxitin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25221-3 Imipenem 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25222-1 Cefmetazole 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25223-9 Doxycycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25224-7 Erythromycin 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25225-4 Minocycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25226-2 Sulfisoxazole 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25227-0 Tobramycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25228-8 Vancomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25229-6 Pyrazinamide 100 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25230-4 Ethambutol 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25231-2 Ethionamide 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25310-4 Amoxicillin+Clavulanate [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 253-5 5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 25366-6 Cefoxitin [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25367-4 Ceftriaxone [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 25411-0 Fleroxacin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 254-3 5-Fluorocytosine [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 25595-0 Econazole [Susceptibility] 2.16.840.1.113883.6.1 0‑L 25596-8 Fosfomycin [Susceptibility] 2.16.840.1.113883.6.1 0‑L 25597-6 Josamycine [Susceptibility] 2.16.840.1.113883.6.1 0‑L 25607-3 Miconazole [Susceptibility] 2.16.840.1.113883.6.1 0‑L 25608-1 Nitroxoline [Susceptibility] 2.16.840.1.113883.6.1 0‑L 25637-0 Econazole [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 25653-7 Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 256-8 Foscarnet [Susceptibility] 2.16.840.1.113883.6.1 0‑L 25702-2 Josamycine [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 25722-0 Miconazole [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 25723-8 Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 25800-4 Tobramycin [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 258-4 Framycetin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 259-2 Framycetin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 2-6 Almecillin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 274-1 Hetacillin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 261-8 Fusidate [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 262-6 Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 263-4 Fusidate [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 265-9 Ganciclovir [Susceptibility] 2.16.840.1.113883.6.1 0‑L 266-7 Gentamicin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 267-5 Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 268-3 Gentamicin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 278-2 Imipenem [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 270-9 Gramicidin D [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 271-7 Gramicidin D [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 272-5 Gramicidin D [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 27-3 Ampicillin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 276-6 Hetacillin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 275-8 Hetacillin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 279-0 Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 280-8 Imipenem [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 28-1 Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 286-5 Isoniazid [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 287-3 Isoniazid [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 288-1 Isoniazid [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 290-7 Kanamycin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 291-5 Kanamycin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 292-3 Kanamycin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 29254-0 Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 29255-7 Linezolid [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 29258-1 Linezolid [Susceptibility] 2.16.840.1.113883.6.1 0‑L 29315-9 Isoniazid 0.4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria 2.16.840.1.113883.6.1 0‑L 294-9 Ketoconazole [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 296-4 Ketoconazole [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 298-0 Lincomycin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 295-6 Ketoconazole [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 29-9 Ampicillin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 299-8 Lincomycin [Susceptibility] by Minimum inhibitory concentration (MIC) 2.16.840.1.113883.6.1 0‑L 300-4 Lincomycin [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 302-0 Lomefloxacin [Susceptibility] by Minimum lethal concentration (MLC) 2.16.840.1.113883.6.1 0‑L 308-7 Loracarbef [Susceptibility] by Disk diffusion (KB) 2.16.840.1.113883.6.1 0‑L 30268-7 Zidovudine [Susceptibility] by Phenotype method 2.16.840.1.113883.6.1 0‑L 30269-5 Lamivudine [Susceptibility] by Phenotype method 2.16.840.1.113883.6.1 0‑L 30270-3 Didanosine [Susceptibility] by Phenotype method 2.16.840.1.113883.6.1 0‑L 30271-1 Zalcitabine [Susceptibility] by Phenotype method 2.16.840.1.113883.6.1 0‑L 30272-9 Stavudine [Susceptibility] by Phenotype method 2.16.840.1.113883.6.1 0‑L 30273-7 Abacavir [Susceptibility] by Phenotype method 2.16.840.1.113883.6.1 0‑L 30274-5 Adefovir [Susceptibility] by Phenotype method 2.16.840.1.113883.6.1 0‑L 30275-2 Nevirapine [Susceptibility] by Phenotype method 2.16.840.1.113883.6.1 0‑L 30276-0 Delavirdine [Susceptibility] by Phenotype method 2.16.840.1.113883.6.1 0‑L 30277-8 Efavirenz [Susceptibility] by Phenotype method 2.16.840.1.113883.6.1 0‑L 30278-6 Indinavir [Susceptibility] by Phenotype method 2.16.840.1.113883.6.1 0‑L 30279-4 Ritonavir [Susceptibility] by Phenotype method 2.16.840.1.113883.6.1 0‑L 30280-2 Nelfinavir [Susceptibility] by Phenotype method 2.16.840.1.113883.6.1 0‑L 30281-0 Saquinavir [Susceptibility] by Phenotype method 2.16.840.1.113883.6.1 0‑L 30282-8 Zidovudine [Susceptibility] by Genotype method 2.16.840.1.113883.6.1 0‑L 30283-6 Lamivudine [Susceptibility] by Genotype method 2.16.840.1.113883.6.1 0‑L 30284-4 Didanosine [Susceptibility] by Genotype method 2.16.840.1.113883.6.1 0‑L 30285-1 Zalcitabine [Susceptibility] by Genotype method 2.16.840.1.113883.6.1 0‑L 30286-9 Stavudine [Susceptibility] by Genotype method 2.16.840.1.113883.6.1 0‑L 30287-7 Abacavir [Susceptibility] by Genotype method 2.16.840.1.113883.6.1 0‑L 30288-5 Adefovir [Susceptibility] by Genotype method 2.16.840.1.113883.6.1 0‑L 30289-3 Nevirapine [Susceptibility] by Genotype method 2.16.840.1.113883.6.1 0‑L 30290-1 Delavirdine [Susceptibility] by Genotype method 2.16.840.1.113883.6.1 0‑L 30291-9 Efavirenz [Susceptibility] by Genotype method 2.16.840.1.113883.6.1 0‑L 30292-7 Indinavir [Susceptibility] by Genotype method 2.16.840.1.113883.6.1 0‑L 30293-5 Ritonavir [Susceptibility] by Genotype method 2.16.840.1.113883.6.1 0‑L 30294-3 Nelfinavir [Susceptibility] by Genotype method 2.16.840.1.113883.6.1 0‑L 30295-0 Saquinavir [Susceptibility] by Genotype method 2.16.840.1.113883.6.1 0‑L 30296-8 Amprenavir [Susceptibility] by Phenotype method 2.16.840.1.113883.6.1 0‑L 30297-6 Amprenavir [Susceptibility] by Genotype method 2.16.840.1.113883.6.1 0‑L 30298-4 Lamivudine [Susceptibility] 2.16.840.1.113883.6.1 0‑L 30299-2 Amprenavir [Susceptibility] 2.16.840.1.113883.6.1 0‑L 30300-8 Didanosine [Susceptibility] 2.16.840.1.113883.6.1 0‑L 30301-6 Zalcitabine [Susceptibility] 2.16.840.1.113883.6.1 0‑L 30302-4 Stavudine [Susceptibility] 2.16.840.1.113883.6.1 0‑L 30303-2 Abacavir [Susceptibility] 2.16.840.1.113883.6.1 Dieses Value Set beinhaltet 1471 Codes. Um die Publikationsgröße überschaubar zu halten, wird nur eine Auswahl (500 Codes) des ganzen Sets von Codes gezeigt.
Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors werden im @nullFlavor Attribut statt in @code angegeben.